Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18156,158,1.44 [1.22-1.69],8.757125720327982e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,16290,140,2.94 [1.77-4.90],3.223728625359416e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,18206,158,1.84 [1.49-2.28],1.3622534089130476e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,18368,157,3.07 [2.01-4.71],2.5468730255673784e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,18477,160,2.38 [1.78-3.18],4.179179098759858e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15792,137,3.22 [2.24-4.61],2.2966343798355319e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16196,139,2.58 [1.63-4.09],5.263592388730104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18801,163,0.30 [0.18-0.52],1.3791904943056971e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,16282,139,4.06 [2.79-5.91],2.485654817422917e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,15945,138,2.88 [2.04-4.08],2.3246344618850206e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,18490,159,1.52 [1.34-1.74],3.0437801280042975e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,18723,163,3.49 [2.06-5.90],3.251918762495444e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,18660,162,2.34 [1.72-3.19],6.54038431115597e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18466,159,1.30 [1.14-1.48],8.708896878525599e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,18548,161,2.31 [1.61-3.29],4.426556494851446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,18723,163,2.99 [2.20-4.07],3.3861203927956805e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,18629,162,2.12 [1.56-2.88],1.6597533287771602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,18584,161,0.52 [0.39-0.69],5.354796325781978e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,16272,137,0.34 [0.22-0.53],9.064205772053876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,18490,159,2.72 [2.13-3.48],8.907941857783628e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,18398,157,0.63 [0.52-0.77],8.38659346889867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,18398,157,2.54 [1.68-3.84],1.0040056241237044e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,16302,138,1.87 [1.42-2.46],8.364508272833733e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",18660,162,3.13 [1.97-4.95],1.174369473040104e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,18398,157,0.34 [0.23-0.50],7.377575458360744e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,15990,134,0.42 [0.27-0.65],9.820029115464082e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,15945,138,3.41 [2.05-5.67],2.395798856934005e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,18722,162,5.02 [2.81-8.96],4.64535979447299e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,18723,162,1.72 [1.40-2.10],1.899895144572557e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,18660,162,2.91 [1.88-4.50],1.649336899555146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,18533,160,1.96 [1.44-2.67],2.1516154977901923e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,18661,160,3.55 [2.03-6.22],9.455696278262374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18671,161,2.03 [1.52-2.70],1.291715335458014e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15945,138,2.50 [1.61-3.88],4.306133949883503e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,15880,135,4.83 [3.17-7.36],2.0392831078931762e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,18369,157,1.48 [1.27-1.73],4.170162260634272e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,18584,161,2.33 [1.69-3.19],1.732952535802917e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,18801,163,1.87 [1.42-2.47],8.823375526600438e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,18801,163,1.81 [1.36-2.42],5.328192421652661e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,18753,162,1.41 [1.25-1.59],1.3350750736738151e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,18660,162,2.12 [1.74-2.58],1.3649521980274196e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,18772,161,2.12 [1.51-2.97],1.2605919216043737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,18240,158,1.93 [1.42-2.62],2.2668882743917253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,18648,157,2.38 [1.83-3.11],1.3965714884875679e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,18398,157,2.56 [1.89-3.46],1.0223042815965195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,18581,162,2.37 [1.62-3.48],9.860133005482774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,18723,162,2.14 [1.48-3.09],5.0010050702324186e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,18661,163,2.33 [1.76-3.09],2.945123205612372e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,18490,159,2.77 [1.94-3.96],2.4267093899219357e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,18512,160,2.07 [1.49-2.89],1.4885748778375784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,18573,162,1.85 [1.43-2.40],3.499655888505572e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,17947,159,2.45 [1.59-3.79],5.395757873768819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,16208,136,2.15 [1.53-3.01],8.523871008417595e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,18723,162,2.72 [1.92-3.84],1.344405738317692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,18753,162,1.82 [1.43-2.31],1.296219749950551e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,16274,138,2.82 [1.90-4.19],2.4895974504983413e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,18398,157,1.67 [1.33-2.11],1.3006180617417258e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,18490,159,1.48 [1.22-1.80],6.436210658751131e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,18584,161,0.42 [0.31-0.58],1.663683015144825e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16196,139,0.44 [0.37-0.54],4.128845036283206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16196,139,2.14 [1.51-3.04],1.91872581528146e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16282,139,2.03 [1.54-2.68],5.740083342822433e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,18584,161,1.85 [1.37-2.51],7.120347223933367e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16250,141,2.17 [1.63-2.88],1.0788211822731923e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,16206,140,2.41 [1.64-3.55],8.12964080176286e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,16282,139,1.38 [1.20-1.57],3.676210082100144e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,18206,159,1.60 [1.39-1.84],2.5399732875736817e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,18629,162,2.38 [1.60-3.54],2.0701337545810144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,16282,139,1.96 [1.43-2.67],2.689182843525441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,18667,162,2.82 [1.94-4.11],5.545758558681485e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,16282,139,1.71 [1.31-2.24],8.436384000827558e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,18585,160,2.32 [1.56-3.45],3.118193545556194e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,18206,158,2.30 [1.58-3.34],1.424229699216379e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,15917,134,0.12 [0.06-0.23],6.32696142715129e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,18533,160,1.64 [1.33-2.03],4.961989473955355e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,18529,161,2.46 [1.63-3.73],2.0910349711641405e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,18156,158,2.07 [1.58-2.71],1.5430482063139904e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,18753,162,1.88 [1.41-2.51],1.671149865496572e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,18671,161,0.46 [0.37-0.59],1.8717468343870432e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,18801,163,0.40 [0.25-0.63],7.346789270255525e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,18608,162,0.46 [0.32-0.66],3.19857415077757e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,18670,163,4.76 [2.82-8.05],5.469232154200894e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,18584,161,2.72 [2.01-3.68],8.107878217967344e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,15945,138,2.08 [1.46-2.97],5.17659113875261e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,18801,163,2.52 [1.89-3.36],2.8526484293083885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,18581,162,3.30 [2.15-5.05],4.029363901112768e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,15945,138,2.34 [1.55-3.53],4.936457859954838e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,18660,162,4.40 [2.39-8.12],2.1227806126200067e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,18801,163,0.35 [0.23-0.53],8.275478676294541e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,18660,162,4.17 [2.72-6.40],5.2760296100284996e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,18640,160,2.54 [1.73-3.72],1.7971211601189294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,18316,162,1.89 [1.41-2.53],2.0574500391396565e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,16282,139,3.35 [2.11-5.30],2.582209210705525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,18581,162,0.65 [0.54-0.79],1.6758271211123314e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,17418,149,1.75 [1.35-2.26],2.1887378668661703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,18584,161,3.10 [1.84-5.24],2.198825850406522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,18533,160,1.82 [1.43-2.31],7.719589709090253e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,18723,162,1.40 [1.22-1.61],2.0644691376004884e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,18723,162,1.48 [1.29-1.69],6.710232879482948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,18753,162,1.99 [1.53-2.59],3.255617583543831e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,18660,162,1.58 [1.32-1.88],3.7413126490263686e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,18723,162,2.96 [1.81-4.86],1.7309445330671963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,18648,157,2.94 [1.97-4.38],1.295384199956065e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,18449,159,1.63 [1.31-2.04],1.1901431467344282e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,18658,163,1.52 [1.24-1.87],6.421916532393564e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,18401,157,2.16 [1.52-3.05],1.4433040904978554e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,16169,140,2.25 [1.63-3.09],6.680238431633517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,18693,163,3.11 [2.07-4.67],4.7928892515879643e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15876,134,1.46 [1.23-1.73],1.0972036376221982e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,18723,163,2.57 [1.95-3.38],1.8728077972749758e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,15876,134,3.61 [2.24-5.82],1.3054136662796125e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18644,161,3.14 [2.13-4.62],6.976144234892929e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,18368,157,2.16 [1.55-3.01],4.635081945052191e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,18156,158,2.03 [1.47-2.79],1.6755712603167004e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17962,153,1.45 [1.22-1.73],2.328315133873627e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,17924,155,2.76 [2.00-3.81],8.177473247338147e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,18801,163,3.09 [1.99-4.79],4.528011888394822e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,18533,160,1.40 [1.21-1.63],1.0108917279637743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,16072,136,0.30 [0.17-0.52],2.2387334150119745e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",18581,162,1.45 [1.27-1.65],3.9434281360993175e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,16282,139,2.57 [1.65-4.01],3.275548196405259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,18533,160,2.04 [1.54-2.70],5.846731596567371e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,18156,158,1.46 [1.25-1.70],1.1923550669219374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,18693,163,1.43 [1.29-1.59],2.9373665740926716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,18697,163,1.47 [1.23-1.77],3.0286591676740657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,18648,157,0.38 [0.25-0.57],2.6698852949011874e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,18648,157,4.83 [2.76-8.43],3.194274740897036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,16290,140,1.93 [1.56-2.39],1.5799710433747935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18398,157,2.61 [1.67-4.08],2.4742082952933616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,15876,134,0.68 [0.56-0.82],4.656836509140532e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,18548,161,3.52 [2.52-4.91],1.592605708248617e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,15945,138,1.62 [1.27-2.07],9.37746988036768e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18723,162,2.54 [1.92-3.35],6.268745448653901e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,16250,141,1.22 [1.11-1.35],5.404428164444905e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,18801,163,2.49 [2.01-3.08],4.751151815452815e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,18693,163,2.74 [1.82-4.11],1.2452446324242249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,15758,137,0.54 [0.41-0.72],2.948420781257074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,18558,160,1.84 [1.48-2.29],5.31572880001492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,15945,138,0.27 [0.15-0.48],5.98066794153608e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,15864,136,1.70 [1.30-2.22],9.721664437854118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,18398,157,0.58 [0.45-0.75],3.7829776132445374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,16196,139,1.66 [1.30-2.13],4.740555607489463e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,18206,158,1.70 [1.39-2.09],2.407499528360521e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",18490,159,1.78 [1.47-2.15],1.9961325478367633e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,18679,162,1.60 [1.30-1.97],9.401598055349091e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,18690,162,2.03 [1.72-2.41],2.728521250228997e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,18753,162,3.31 [2.45-4.48],8.493627710660283e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18533,160,2.61 [1.77-3.84],1.0862276344805175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18451,159,2.88 [1.98-4.18],2.7385002310529446e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,18494,161,3.87 [2.31-6.46],2.44474178037878e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,18505,160,2.85 [1.91-4.23],2.41550220272354e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,18584,161,1.88 [1.38-2.55],5.419858901332877e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15787,134,2.69 [1.92-3.76],9.841486599596327e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,18772,163,1.26 [1.12-1.42],9.693699575261958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,18781,163,1.76 [1.39-2.22],2.818112662111276e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,18671,161,0.29 [0.21-0.40],4.259189031723861e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,18342,158,1.83 [1.45-2.32],4.60410369228008e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,18801,163,2.78 [2.09-3.72],3.613579270244429e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18584,161,2.68 [1.91-3.77],1.1504594966265011e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,16270,137,2.42 [1.75-3.36],1.1743482113924421e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,18490,159,1.99 [1.52-2.61],5.603659810975005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,18660,162,3.07 [2.12-4.45],2.866057785485076e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,18533,160,2.48 [1.66-3.69],8.074211935858238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,18522,161,1.84 [1.38-2.44],3.074794204181252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,18671,161,2.75 [1.89-4.00],1.127681986363233e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,18114,158,1.85 [1.59-2.15],2.7474417107974414e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,18558,160,3.23 [1.83-5.67],4.747556604201737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,18585,160,0.39 [0.28-0.55],7.46772405599966e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,18745,163,2.26 [1.70-2.99],1.3829251327463956e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,18225,158,0.26 [0.19-0.37],5.3211782583201626e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,16206,140,1.73 [1.44-2.08],3.6233036953385837e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,18417,160,2.50 [1.87-3.34],7.266908794885804e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,18533,160,2.21 [1.62-3.01],4.429903041245586e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,18490,159,1.67 [1.49-1.87],3.6310319321171137e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,15945,138,1.76 [1.35-2.29],2.412489640283841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,16282,139,2.24 [1.62-3.11],1.3283799299896898e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,18597,156,1.88 [1.42-2.50],1.370195576608423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,18478,156,2.29 [1.76-2.98],6.62636014565334e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,18723,163,1.65 [1.37-1.98],1.3820680235226145e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,17978,152,2.03 [1.42-2.88],8.595616714213031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,15946,135,0.17 [0.09-0.31],4.940440022729664e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18581,162,2.45 [1.86-3.24],2.7165404449945757e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,18722,162,1.79 [1.40-2.31],4.715134565810966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,18369,157,2.01 [1.44-2.80],3.950312022421797e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,18671,161,1.86 [1.48-2.35],1.266639402383334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,16290,140,0.24 [0.13-0.46],1.2526895766826235e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,18034,153,1.89 [1.42-2.51],1.1688222541238511e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,18619,161,0.57 [0.43-0.75],6.880441368009113e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,16302,138,2.86 [1.94-4.22],1.0120494911564633e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,18581,162,2.00 [1.60-2.49],7.14398369013708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,18496,160,2.00 [1.54-2.59],1.5342529797243613e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,18573,162,2.66 [1.80-3.92],7.998346607170662e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,18660,162,2.73 [1.88-3.95],1.264343732754352e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18550,161,3.00 [1.96-4.58],4.01888223908768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,17932,154,1.63 [1.30-2.04],2.3066605497708626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,18801,163,2.22 [1.52-3.24],3.226555719960091e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,18499,162,3.38 [2.31-4.94],3.5400514902831973e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,18398,157,3.32 [2.44-4.52],2.3778490516124574e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,18156,158,1.65 [1.32-2.06],1.229698119224587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,18607,162,2.96 [1.90-4.63],1.6865930274442585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,18606,156,1.72 [1.40-2.10],1.8789968480439082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,15945,138,0.17 [0.09-0.33],6.958641426921635e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,18584,161,0.68 [0.60-0.76],5.694511341259827e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,18536,161,1.55 [1.24-1.93],9.357581601477374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,18575,161,1.94 [1.56-2.41],2.65306006140526e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,18585,160,1.72 [1.40-2.11],2.178654023543213e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,18175,158,2.17 [1.60-2.94],5.018550403145025e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,18691,161,1.53 [1.28-1.83],2.6064677455194075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,18550,160,1.61 [1.27-2.05],7.67524346157587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,16290,140,4.45 [2.80-7.08],2.9298420257974715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,18723,162,2.21 [1.65-2.96],8.748583926762615e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,18225,158,1.46 [1.24-1.73],6.829938585567486e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,18638,162,2.41 [1.93-3.01],1.1343298375483375e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18648,157,3.01 [1.90-4.79],3.060569364896344e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16196,139,2.87 [1.96-4.21],6.108703373940036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,18550,161,2.77 [1.90-4.05],1.2308683376322348e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,18648,157,2.28 [1.66-3.13],3.6957615524107387e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,18753,162,2.80 [1.81-4.35],3.986766901155506e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,15545,136,4.03 [2.43-6.67],6.678287218349827e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,18607,162,2.51 [1.61-3.90],4.430831345778336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",18150,155,1.68 [1.40-2.01],1.5265503067162986e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,15997,138,2.44 [1.77-3.36],4.596365890715885e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,18584,161,2.12 [1.55-2.89],2.034238405357766e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,18206,158,1.24 [1.12-1.37],2.7578496699696576e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,18533,160,1.59 [1.29-1.97],1.8308528808120097e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,16282,139,2.49 [1.64-3.78],1.916801450455102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,16250,141,2.23 [1.57-3.17],7.17303586805514e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18584,161,1.38 [1.25-1.53],4.3139961012720575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,16246,139,2.41 [1.85-3.14],7.325535243662782e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18607,162,2.90 [1.92-4.38],4.141906495870902e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,16250,141,2.20 [1.56-3.11],7.702870248344619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,16206,140,2.12 [1.49-3.04],3.451431211866237e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,18753,162,3.57 [2.40-5.32],3.963313657026141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,16196,139,1.86 [1.39-2.48],2.464999800025841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,18354,160,1.87 [1.55-2.26],4.903490179814422e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,18345,158,3.60 [2.59-5.02],3.441033240067675e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18585,160,2.26 [1.52-3.36],6.0432191690574445e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18585,160,2.82 [2.03-3.92],7.710349037579013e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,18584,161,1.99 [1.52-2.60],4.95363109209434e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,18648,157,4.16 [2.60-6.64],2.413503143989319e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,18778,163,0.58 [0.45-0.76],5.791582621222248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",18528,161,1.48 [1.22-1.79],6.489884492195864e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,18745,163,2.06 [1.57-2.70],1.633695608500158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,18464,162,5.45 [3.65-8.16],1.38519563507715e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,16290,140,0.39 [0.25-0.63],8.205299012325763e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,18660,162,0.47 [0.35-0.64],9.021306783198688e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,16282,139,2.55 [1.68-3.87],1.2122443564497742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,16282,139,1.86 [1.38-2.50],4.266201394534287e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,18634,161,0.31 [0.18-0.52],9.635439945999524e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,15792,137,2.18 [1.64-2.89],7.60250359451687e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,18503,162,2.84 [2.13-3.80],1.711398087304702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,16114,139,2.81 [1.94-4.08],4.7024931486147526e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,18533,160,1.25 [1.12-1.40],9.037551156015954e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,18437,159,2.10 [1.48-2.98],2.9849751857540543e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,18206,158,1.77 [1.37-2.29],1.259752668365918e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16196,139,3.04 [1.78-5.18],4.359656129094189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,18723,162,2.40 [1.74-3.31],1.123420803934898e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,16302,138,0.48 [0.35-0.66],3.54222275751806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,16246,139,2.09 [1.60-2.73],6.122435333440214e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,18585,160,2.66 [1.87-3.79],6.393394582438704e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,18584,161,1.53 [1.34-1.74],3.81817022878236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,16290,140,2.56 [1.71-3.84],5.4449607825522585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,16178,140,2.17 [1.65-2.84],2.7759813981656653e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,18734,162,3.81 [2.54-5.71],1.0811583143967448e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,15876,134,3.02 [2.00-4.57],1.555696602878559e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,18398,157,2.18 [1.53-3.09],1.3414371706676836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,18057,153,2.38 [1.72-3.29],1.639734840476169e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,15807,134,2.12 [1.55-2.90],2.5927275504386622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,18584,161,1.96 [1.48-2.59],2.7174808107225944e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,15876,134,2.19 [1.62-2.97],4.103773239338969e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,16302,138,0.23 [0.11-0.47],4.810880357066104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,16227,141,2.16 [1.50-3.12],3.782480825114413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16010,137,0.15 [0.08-0.28],3.3450192205930355e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,16062,137,0.29 [0.16-0.53],6.778768369502374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,16282,139,2.64 [1.87-3.73],3.8131067016545734e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,18618,156,1.96 [1.45-2.66],1.358593147492978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,18660,162,2.48 [1.84-3.33],1.873819649765301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18533,160,2.01 [1.41-2.85],9.509576478860117e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,18555,162,1.88 [1.43-2.48],7.434472883789266e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,18225,158,1.61 [1.28-2.04],5.896733129747672e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,18533,160,1.78 [1.44-2.19],7.337038705982738e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,18156,158,2.00 [1.54-2.60],2.464387761626153e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,18660,162,2.54 [1.88-3.42],8.678081492641852e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,18633,160,1.90 [1.48-2.44],4.85052874402005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",18585,160,1.87 [1.37-2.54],6.490990322917197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,16274,138,2.44 [1.57-3.80],7.981074800352915e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,18585,160,1.70 [1.31-2.19],5.722361094714776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,18531,159,2.90 [1.92-4.37],3.7703893862641353e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,18607,162,2.38 [1.71-3.32],3.175575303502391e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,18496,160,3.03 [2.14-4.28],3.505746422293342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18550,161,0.76 [0.66-0.87],4.207328434279223e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18801,163,2.81 [1.94-4.05],3.99515647115889e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,16421,136,2.50 [1.68-3.72],5.693908731798916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,15963,138,2.23 [1.58-3.14],5.3784677304766575e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,18629,162,1.70 [1.38-2.09],5.121716095266393e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,18569,159,1.61 [1.27-2.04],9.589333971509652e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,18598,156,1.58 [1.27-1.97],4.394722693065942e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,18533,160,2.01 [1.57-2.58],2.9885806245210954e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,18722,162,2.44 [1.78-3.36],3.8732393418596736e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,18648,157,2.39 [1.75-3.28],5.2249578815216854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,18585,160,2.37 [1.79-3.14],1.9417344860499822e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,18389,158,3.32 [2.34-4.72],1.7396689715349543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,18585,160,2.16 [1.65-2.82],1.57162932981484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,15876,134,1.75 [1.39-2.20],1.8855935517677217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,18671,161,1.93 [1.47-2.54],2.5182988708354646e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18398,157,2.75 [2.03-3.73],7.852321554141656e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18398,157,1.64 [1.38-1.95],1.639350062933469e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18753,162,1.95 [1.45-2.61],7.749453392098926e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18581,162,2.98 [1.97-4.49],2.207696228125184e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18648,157,2.47 [1.79-3.40],3.0409556343015405e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18607,162,2.99 [2.07-4.30],4.342903540136509e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18723,163,2.03 [1.45-2.84],4.014414919953944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18585,160,2.94 [2.08-4.16],9.57279034062578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18585,160,1.82 [1.46-2.26],6.875810793442339e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18722,162,2.04 [1.50-2.77],4.9878993747539e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18398,157,1.74 [1.42-2.13],1.1812329714197385e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18398,157,1.64 [1.29-2.09],6.0356196424121735e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18660,162,3.84 [2.39-6.17],2.506573451955668e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,18458,161,1.98 [1.56-2.52],2.4929791007519004e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,16127,136,0.14 [0.08-0.25],1.3291893182387702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,18648,157,3.76 [2.32-6.09],7.478924318009853e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,18723,162,1.54 [1.25-1.88],3.102704187340567e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,18398,157,2.12 [1.55-2.90],2.8427549091721886e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,18748,163,0.53 [0.42-0.66],7.67385851471465e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,18206,158,1.51 [1.25-1.82],1.4819454755035732e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,18634,161,2.54 [1.64-3.95],3.3419179462746665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,15792,137,5.19 [3.08-8.74],5.897970529621354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,16274,138,2.21 [1.49-3.29],7.707710168026114e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,16206,140,1.72 [1.40-2.10],1.3237863573451854e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,18562,159,2.14 [1.62-2.84],1.1392793522623093e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,18693,163,2.40 [1.75-3.29],5.1680764338419655e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,18694,162,1.62 [1.35-1.95],3.494828796506668e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,17672,144,2.55 [2.00-3.26],4.160603543200688e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18330,156,0.51 [0.37-0.70],3.177532182412566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,18206,158,1.73 [1.38-2.17],1.953035897859318e-06
